Research On The Construction Of Credit System In Chinese Pharmaceutical Market

With the deep advancement of market economic system and legal system after China became a member of WTO, the credit problem is becoming increasingly concerned by the central government, and by common people, at the same time, for which are called by enterprises. The problem of lacking credit in current pharmaceutical market has seriously restricted the continuous development of pharmaceutical economy. Therefore the construction of credit system in pharmaceutical market has important realistic significance to leading enterprises self-discipline, enhancing long-term supervision and formalizing standardized economic order in pharmaceutical market. So combining the credit management theory with the speciality of pharmaceutical market, the paper sets up the frame of credit system in pharmaceutical market matching the state condition.First, the paper clarified special concept of pharmaceutical enterprise credit and credit system in pharmaceutical market, and analyzed economic theory of credit distinctively. The cause of lacking credit in pharmaceutical market was analyzed by applying the theory of comparing cost with benefit. Through analyzing the paper draw conclusions that the fundamental strategy of solving the problem of lacking credit in pharmaceutical market is to establish credit system. Then the paper analyzed the current credit system construction in pharmaceutical market in China. Credit system in pharmaceutical market is underway successfully. But it is still in the exploring stage now. There are some problems affecting comprehensive development of credit system in pharmaceutical market.Based on the theory and demonstration analysis, the corresponding strategies for constructing perfect credit system in pharmaceutical market were put forward by drawing experience from abroad. Firstly we should adopt dynamic mechanism mode and develop it step by step, which is driven by the government and founded on market operation. Secondly, the paper put forward some concrete countermeasures. The countermeasures involve enhancing credit consciousness of pharmaceutical enterprises, establishing complete credit laws,...